KitoZyme - Capital increase - 9 million EUR

KitoZyme, an innovative company active in the biochemistry sector and a leader in its market segment, has announced the recent finalization of a capital increase for a total amount of 9 million euros.

The issue of new shares was reserved for and entirely underwritten by the company’s two main shareholders: the company Valois (Mestdagh Group and Montulet family) and the SRIW, the Wallonia Regional Investment Company.

This capital increase will significantly build the company’s equity and will allow it to actively continue developing new products and its international commercial expansion.

About us